|
ZNF512B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.026000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.809700E-02 |
| Normal-vs-Stage2 |
9.687800E-01 |
| Normal-vs-Stage3 |
6.416600E-01 |
| Normal-vs-Stage4 |
3.024200E-02 |
| Stage1-vs-Stage2 |
3.659400E-01 |
| Stage1-vs-Stage3 |
6.041000E-01 |
| Stage1-vs-Stage4 |
6.051600E-02 |
| Stage2-vs-Stage3 |
7.163200E-01 |
| Stage2-vs-Stage4 |
2.644200E-01 |
| Stage3-vs-Stage4 |
1.601040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.258200E-02 |
| Normal-vs-AfricanAmerican |
8.062600E-01 |
| Normal-vs-Asian |
3.830600E-01 |
| Caucasian-vs-AfricanAmerican |
1.888980E-01 |
| Caucasian-vs-Asian |
2.299200E-01 |
| AfricanAmerican-vs-Asian |
3.664000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.892000E-02 |
| Normal-vs-Female |
1.245630E-01 |
| Male-vs-Female |
7.778000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.467800E-01 |
| Normal-vs-Extreme_Weight |
7.510800E-01 |
| Normal-vs-Obese |
4.556000E-02 |
| Normal-vs-Extreme_Obese |
2.904400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.792400E-01 |
| Normal_Weight-vs-Obese |
9.067900E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.024000E-01 |
| Extreme_Weight-vs-Obese |
9.537800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.222400E-01 |
| Obese-vs-Extreme_Obese |
6.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.208480E-02 |
| Normal-vs-Age(41-60Yrs) |
1.052410E-02 |
| Normal-vs-Age(61-80Yrs) |
5.846000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.310000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.953600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.508000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.598110E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.832300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.404000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.052800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.995980E-03 |
| Normal-VS-Type2 PRCC |
1.898050E-02 |
| Normal-VS-KIRP CIMP |
9.417400E-01 |
| Normal-VS-Unclassified PRCC |
6.477800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.93690000038771E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.256600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.453790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.475400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.183200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.533010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.145600E-01 |
| Normal-vs-N1 |
4.678000E-01 |
| Normal-vs-N2 |
2.410200E-01 |
| N0-vs-N1 |
3.900200E-01 |
| N0-vs-N2 |
6.342200E-01 |
| N1-vs-N2 |
3.600400E-01 |
|
|
